MindWave secures 12-month technology services deal with Singapore-based AQUAE
What happened
MindWave Innovations Inc., a subsidiary of Apimeds Pharmaceuticals US, Inc., has signed a 12-month technology services agreement with Singapore-based AQUAE Holdings Pte. Ltd. The agreement tasks MindWave with designing, developing, deploying, and hosting AQUAEChain, a platform for insured ALCI Credits. MindWave will receive contracted fees and an allocation equal to 20% of the total ALCI Credits issued and outstanding on the network.
From manilatimes.net
Why it matters
The partnership allows MindWave to expand its business into the technology services sector. For AQUAE, the platform establishes a new market for its ALCI Credits methodology and brand.
The agreement is discussed in the context of comparing high cost of living and property tax burdens in markets including New Jersey, New York City, and Singapore.
From manilatimes.net
Who's involved
- New JerseyMindWave Innovations Inc. is the technology provider under the agreement.
- SingaporeAQUAE Holdings Pte. Ltd. is the Singapore-based company leading the ALCI Credits methodology.
Keep exploring
The entities involved
-
New Jersey
state of the United States of America
-
Singapore
sovereign island country and city-state in maritime Southeast Asia